T 1958/16 (IL-B50 antagonists for treating allergic diseases/MERK) of 06.08.2020
- European Case Law Identifier
- ECLI:EP:BA:2020:T195816.20200806
- Date of decision
- 6 August 2020
- Case number
- T 1958/16
- Petition for review of
- -
- Application number
- 01273862.1
- IPC class
- A61K 38/17
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Antagonist antibodies of a mammalian cytokine or its receptor for the treatment of allergy
- Applicant name
- Merck Sharp & Dohme Corp.
- Opponent name
- Thirkettle, Linda Elke (opposition withdrawn)
Novartis AG
Dr. H. Ulrich Dörries - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2)European Patent Convention Art 54European Patent Convention Art 56European Patent Convention Art 83
- Keywords
- Amendments - allowable (yes);
Sufficiency of disclosure - (yes);
Novelty - (yes);
Inventive step - (yes) - Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the opposition division with the order to maintain the patent on the basis of the claims of the main request, filed during the oral proceedings of 6 August 2020, and a description to be adapted thereto.